Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05101629
Title Pembrolizumab and Lenvatinib in Patients With Advanced HCC Who Are Refractory to Atezolizumab and Bevacizumab Therapy
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Institut fur Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Age Groups: adult | senior
Covered Countries DEU

Facility Status City State Zip Country Details
Charité-Universitätsmedizin Berlin Recruiting Berlin 13353 Germany Details
Medizinische Hochschule Hannover Not yet recruiting Hannover 30625 Germany Details
*Shaded cells indicate that there was no data available from for the field